Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phase I study of albinterferon alfa 2b in Japanese chronic hepatitis C patients
jRCT2080220591Phase 1
- Sponsor
- Novartis
- Start
- Aug 2008
- Modality
- Fc-Fusion Proteins → Carrier/Scaffold Proteins → Recombinant Proteins and Enzymes
- Countries
- 1
01
Overview
Phase 1, single-arm trial of albinterferon alfa-2b in hepatitis C virus infection, sponsored by Novartis.
02
Drugs
albinterferon alfa-2b
03
Conditions
hepatitis C virus infection
Beyond the preview
Go deeper on jRCT2080220591.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCT2080220591.